Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients

A Nadasdi, G Sinkovits, I Bobek, B Lakatos… - Biomarkers in …, 2022 - Taylor & Francis
Aim: To investigate the serum circulating DPP4 activity in patients with COVID-19 disease.
Materials & methods: Serum samples from 102 hospitalized COVID-19 patients and 43 post …
被引用次数：12 相关文章
[HTML] nih.gov

[HTML][HTML] Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients

Á Nádasdi, G Sinkovits, I Bobek, B Lakatos… - Biomarkers in …, 2022 - ncbi.nlm.nih.gov
Aim: To investigate the serum circulating DPP4 activity in patients with COVID-19 disease.
Materials & methods: Serum samples from 102 hospitalized COVID-19 patients and 43 post …

Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients

Á Nádasdi, G Sinkovits, I Bobek… - Biomarkers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Aim: To investigate the serum circulating DPP4 activity in patients with COVID-19 disease.
Materials & methods: Serum samples from 102 hospitalized COVID-19 patients and 43 post …

Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients.

Á Nádasdi, G Sinkovits, I Bobek, B Lakatos… - Biomarkers in …, 2022 - europepmc.org
Aim: To investigate the serum circulating DPP4 activity in patients with COVID-19 disease.
Materials & methods: Serum samples from 102 hospitalized COVID-19 patients and 43 post …

Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients

Á Nádasdi, G Sinkovits, I Bobek… - Biomarkers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Aim: To investigate the serum circulating DPP4 activity in patients with COVID-19 disease.
Materials & methods: Serum samples from 102 hospitalized COVID-19 patients and 43 post …